These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32268981)

  • 1. Does LH suppression by progesterone-primed ovarian stimulation compared with GnRH antagonist affect live birth rate among oocyte recipients?
    Martínez F; Clúa E; García S; Coroleu B; Polyzos NP; Barri PN
    Reprod Biomed Online; 2020 May; 40(5):661-667. PubMed ID: 32268981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian response in oocyte donation cycles under LH suppression with GnRH antagonist or desogestrel progestin: retrospective and comparative study.
    Martínez F; Rodriguez-Purata J; Clua E; Garcia S; Coroleu B; Polyzos N
    Gynecol Endocrinol; 2019 Oct; 35(10):884-889. PubMed ID: 31081407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone-primed ovarian stimulation in oocyte donation: a model for elective fertility preservation?
    Devesa M; Racca A; Clúa E; Casato C; García S; Polyzos NP; Martínez F
    Reprod Biomed Online; 2022 Jun; 44(6):1015-1022. PubMed ID: 35339364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial.
    Beguería R; García D; Vassena R; Rodríguez A
    Hum Reprod; 2019 May; 34(5):872-880. PubMed ID: 30927417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desogestrel versus antagonist injections for LH suppression in oocyte donation cycles: a crossover study.
    Martínez F; Rodriguez-Purata J; Beatriz Rodríguez D; Clua E; Rodriguez I; Coroleu B
    Gynecol Endocrinol; 2019 Oct; 35(10):878-883. PubMed ID: 31062995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.
    Giles J; Alama P; Gamiz P; Vidal C; Badia P; Pellicer A; Bosch E
    Fertil Steril; 2021 Aug; 116(2):404-412. PubMed ID: 33814126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank.
    Hipp HS; Gaskins AJ; Nagy ZP; Capelouto SM; Shapiro DB; Spencer JB
    Hum Reprod; 2020 Apr; 35(4):847-858. PubMed ID: 32142582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].
    Kdous M; Chaker A; Bouyahia M; Zhioua F; Zhioua A
    Tunis Med; 2009 Dec; 87(12):834-42. PubMed ID: 20209851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation.
    Popovic-Todorovic B; Santos-Ribeiro S; Drakopoulos P; De Vos M; Racca A; Mackens S; Thorrez Y; Verheyen G; Tournaye H; Quintero L; Blockeel C
    Hum Reprod; 2019 Oct; 34(10):2027-2035. PubMed ID: 31560740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian stimulation for oocyte donation: a systematic review and meta-analysis.
    Martinez F; Racca A; Rodríguez I; Polyzos NP
    Hum Reprod Update; 2021 Jun; 27(4):673-696. PubMed ID: 33742206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation].
    Crha I; Ventruba P; Filipinská E; Dziakova M; Žáková J; Ješeta M; Lousová E; Papíková Z
    Ceska Gynekol; 2018; 83(1):11-16. PubMed ID: 29510633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.
    Itskovitz-Eldor J; Kol S; Mannaerts B
    Hum Reprod; 2000 Sep; 15(9):1965-8. PubMed ID: 10966996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality.
    Racca A; De Munck N; Santos-Ribeiro S; Drakopoulos P; Errazuriz J; Galvao A; Popovic-Todorovic B; Mackens S; De Vos M; Verheyen G; Tournaye H; Blockeel C
    Hum Reprod; 2020 Jan; 35(1):167-174. PubMed ID: 31953546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
    [No Abstract]   [Full Text] [Related]  

  • 20. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
    Lainas GT; Lainas TG; Sfontouris IA; Chatzimeletiou K; Venetis CA; Bosdou JK; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Sep; 34(9):1770-1777. PubMed ID: 31384921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.